Neuromod
Neuromodulation tinnitus treatment device manufacturer.
5
Funding Rounds
$41.1m
Money raised
Overview
Neuromodulation tinnitus treatment device manufacturer.
-
Website:
- Business model: B2C
- Headquarters: Dublin
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Neuromod has raised a total of $11.28m in funding over 5 rounds.
Key Insights:
- Neuromod Series B Round, March 2025: $11m
- Neuromod Seed funding round, June 2011: $284.24k
- Neuromod Devices funding round, September 2019: $9.4m
- Neuromod Series B round, October 2020: $12.4m
- Neuromod Series A round, September 2015: $8m
Neuromod Series B Round, March 2025
$11m
Neuromod Seed funding round, June 2011
$284.24k
Neuromod Devices funding round, September 2019
$9.4m
Neuromod Series A round, September 2015
$8m
Neuromod Series B round, October 2020
$12.4m
Industries
Neuromod is active in the following industries: